Self-Monitoring OCT
Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth
1 other identifier
interventional
100
1 country
1
Brief Summary
The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation. Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging. In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
May 13, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2027
Study Completion
Last participant's last visit for all outcomes
December 15, 2027
May 13, 2026
May 1, 2026
1.5 years
May 7, 2026
May 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Number of inner retinal abnormalities detected as measured by OCT images
Up to 60 minutes
Number of outer retinal abnormalities detected as measured by OCT images.
Up to 60 minutes
Sensitivity as measured by OCT images.
Up to 60 mins
Specificity as measured by OCT images.
Up to 60 mins
Positive predictive value (PPV) as measured by OCT images.
Up to 60 mins
Negative predictive value (NPV) as measured by OCT images.
Up to 60 mins
Secondary Outcomes (3)
Image-quality as recorded by nurse coordinator during patient interaction with the device.
Up to 60 mins
Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.
Up to 60 mins
Number of repeated attempts
Up to 60 mins
Study Arms (2)
Self-administered OCT Images
EXPERIMENTALParticipants will use an OCT device to obtain OCT images of the eyes.
Technician-acquired OCT
ACTIVE COMPARATORTechnicians will use a standard OCT device to obtain OCT images of the eyes as per standard of care.
Interventions
Self-administered OCT imaging using modified portable OCT with headrest and software workflow to enable patient self-operation and secure image transfer to a remote reading center.
Technician-acquired OCT obtained using routine clinical equipment during the same visit
Eligibility Criteria
You may qualify if:
- \. Provision of signed and dated informed consent.
- \. Age ≥ 18 years.
- \. Presenting for care at a University Hospitals Eye Institute clinic
- \. Willing to complete study questionnaires.
- \. Scheduled to undergo standard technician-acquired OCT
You may not qualify if:
- \. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures.
- \. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position).
- \. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe.
- \. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time.
- \. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented).
- \. Patients with visual acuity \<20/200.
- \. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Warren Sobol, MD
University Hospitals Cleveland Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician
Study Record Dates
First Submitted
May 7, 2026
First Posted
May 13, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
December 15, 2027
Study Completion (Estimated)
December 15, 2027
Last Updated
May 13, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share